SCHEMBL5670586

SCHEMBL5670586

CCC1Sc2ccccc2N=C1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 3/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BACE1 P56817 1/20 0.34
PKM P14618 1/20 0.34
BCHE P06276 5/20 0.33
NOS1 P29475 5/20 0.33
NOS3 P29474 3/20 0.33
NOS2 P35228 3/20 0.33
ACHE P22303 2/20 0.33
UTS2R Q9UKP6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5672876 0.87 KDM4E (0.36) KDM4EGAARAB9AMAPTNPC1
SCHEMBL5671406 0.84 KDM4E (0.34) KDM4EGAARAB9AMAPTNPC1
SCHEMBL5670578 0.77 KDM4E (0.41) KDM4EGAARAB9AMAPTNPC1
SCHEMBL7708239 0.74 NOS3 (0.40) MAPTSMN1; SMN2NOS1NOS3NOS2
SCHEMBL5670415 0.72 KDM4E (0.38) KDM4EGAARAB9AMAPTNPC1
SCHEMBL19804816 0.66 NOS1 (0.47) KDM4EGAAALDH1A1ALOX15HSD17B10
SCHEMBL9511908 0.63 BCHE (0.40) KDM4ERAB9AMAPTNPC1SMN1; SMN2
SCHEMBL5673722 0.62 ESR1 (0.40) KDM4EGAARAB9AMAPTNPC1
SCHEMBL9635267 0.60 MAPT (0.36) KDM4EGAARAB9AMAPTNPC1
SCHEMBL10876774 0.59 MAPT (0.35) KDM4ERAB9AMAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0980362-B1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AG (DE) 2006-08-16 EP claimed
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US claimed
EP-0980362-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2000-02-23 EP claimed
WO-1998050372-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-11-12 WO claimed
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed